var FO = { movie:"http://www.the-scientist.com/supplementary/flash/54376/54376.swf", width:"520", height:"680", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Slideshow: This year's BPTW Postdocs in pictures In our March issue, review the institutions that ranked at the top of our 6th annual Best Places to Work for Postdoc survey. Click here to view interactive sortable charts of the top ranked institutions in 2008. Click here to v
In our March issue, review the institutions that ranked at the top of our 6th annual Best Places to Work for Postdoc survey. Click here to view interactive sortable charts of the top ranked institutions in 2008. Click here to view the printable PDF.
Below, take a look at some of this year's winning institutions in the US and abroad
Please download the Adobe Flash Player to view this content:
Gladstone: Attentive at the top
Slideshow: Top 2008 Institutions
These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".
View this Issue
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.
In our next roundtable webinar, learn how scientists leverage spatial biology to map tissues, uncover cellular interactions, and advance disease research.
Discover how scientists use the latest gene editing tools to advance health research.
Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.
Ten-year Agreement to Provide a Secure, AI-enabled Forensic Laboratory Information Management System Supporting DHS Forensic, Scientific, and Testing Services
deliver robust, reproducible solutions for sample preparation enabling a new era of end-to-end standardization in proteomics
Enables higher-throughput, cost effective single-cell sequencing
Enables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs
